Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Annovis Bio Inc (NYSE: ANVS) closed at $1.7 down -22.73% from its previous closing price of $2.2. In other words, the price has decreased by -$22.73 from its previous closing price. On the day, 7.77 million shares were traded. ANVS stock price reached its highest trading level at $1.79 during the session, while it also had its lowest trading level at $1.605.
Ratios:
For a deeper understanding of Annovis Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.65 and its Current Ratio is at 7.65. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 25, 2024, Maxim Group Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $25.
On December 29, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $36.Canaccord Genuity initiated its Buy rating on December 29, 2023, with a $36 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANVS now has a Market Capitalization of 33126596 and an Enterprise Value of 15996307.
Stock Price History:
The Beta on a monthly basis for ANVS is 1.61, which has changed by -0.77363515 over the last 52 weeks, in comparison to a change of 0.118204355 over the same period for the S&P500. Over the past 52 weeks, ANVS has reached a high of $10.54, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is -28.40%, while the 200-Day Moving Average is calculated to be -33.75%.
Shares Statistics:
For the past three months, ANVS has traded an average of 377.29K shares per day and 1827520 over the past ten days. A total of 19.49M shares are outstanding, with a floating share count of 16.59M. Insiders hold about 14.87% of the company’s shares, while institutions hold 14.43% stake in the company. Shares short for ANVS as of 1759190400 were 1398175 with a Short Ratio of 3.71, compared to 1756425600 on 1708692. Therefore, it implies a Short% of Shares Outstanding of 1398175 and a Short% of Float of 8.37.
Earnings Estimates
. The current market rating for Annovis Bio Inc (ANVS) reflects the collective analysis of 1 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.4, with high estimates of -$0.4 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.43 and -$1.43 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$0.82, with 2.0 analysts recommending between -$0.3 and -$1.34.
